Page last updated: 2024-08-24

geneserine and ganstigmine

geneserine has been researched along with ganstigmine in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brossi, A; Greig, NH; Holloway, HW; Whittaker, NF; Yu, QS; Zhu, X	1
Amari, G; Bartolucci, C; Bolzoni, PT; Delcanale, M; Ghidini, E; Lamba, D; Racchi, M; Siotto, M; Villetti, G	1

Other Studies

2 other study(ies) available for geneserine and ganstigmine

Article	Year
Anticholinesterase activity of compounds related to geneserine tautomers. N-Oxides and 1,2-oxazines. Journal of medicinal chemistry, 2002, Aug-15, Volume: 45, Issue:17 Topics: Acetylcholinesterase; Alkaloids; Butyrylcholinesterase; Cholinesterase Inhibitors; Cyclic N-Oxides; Humans; Isomerism; Oxazines; Structure-Activity Relationship	2002
Structural determinants of Torpedo californica acetylcholinesterase inhibition by the novel and orally active carbamate based anti-alzheimer drug ganstigmine (CHF-2819). Journal of medicinal chemistry, 2006, Aug-24, Volume: 49, Issue:17 Topics: Acetylcholinesterase; Administration, Oral; Alkaloids; Alzheimer Disease; Animals; Binding Sites; Brain; Carbamates; Cholinesterase Inhibitors; Crystallization; Crystallography, X-Ray; Drug Evaluation, Preclinical; Enzyme Activation; Male; Mice; Models, Molecular; Molecular Conformation; Stereoisomerism; Structure-Activity Relationship; Torpedo	2006

Article

Year

Anticholinesterase activity of compounds related to geneserine tautomers. N-Oxides and 1,2-oxazines.

Journal of medicinal chemistry, 2002, Aug-15, Volume: 45, Issue:17

Topics: Acetylcholinesterase; Alkaloids; Butyrylcholinesterase; Cholinesterase Inhibitors; Cyclic N-Oxides; Humans; Isomerism; Oxazines; Structure-Activity Relationship

2002

Structural determinants of Torpedo californica acetylcholinesterase inhibition by the novel and orally active carbamate based anti-alzheimer drug ganstigmine (CHF-2819).

Journal of medicinal chemistry, 2006, Aug-24, Volume: 49, Issue:17

Topics: Acetylcholinesterase; Administration, Oral; Alkaloids; Alzheimer Disease; Animals; Binding Sites; Brain; Carbamates; Cholinesterase Inhibitors; Crystallization; Crystallography, X-Ray; Drug Evaluation, Preclinical; Enzyme Activation; Male; Mice; Models, Molecular; Molecular Conformation; Stereoisomerism; Structure-Activity Relationship; Torpedo

2006